A detailed history of Bcgm Wealth Management, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Bcgm Wealth Management, LLC holds 4,113 shares of LLY stock, worth $3.48 Million. This represents 1.37% of its overall portfolio holdings.

Number of Shares
4,113
Previous 3,950 4.13%
Holding current value
$3.48 Million
Previous $3.07 Million 21.19%
% of portfolio
1.37%
Previous 1.16%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 30, 2024

BUY
$724.87 - $909.04 $118,153 - $148,173
163 Added 4.13%
4,113 $3.72 Million
Q1 2024

May 07, 2024

BUY
$592.2 - $792.28 $8,290 - $11,091
14 Added 0.36%
3,950 $3.07 Million
Q4 2023

Feb 08, 2024

SELL
$525.19 - $619.13 $107,138 - $126,302
-204 Reduced 4.93%
3,936 $2.29 Million
Q3 2023

Nov 08, 2023

BUY
$434.7 - $599.3 $8,259 - $11,386
19 Added 0.46%
4,140 $2.22 Million
Q2 2023

Aug 07, 2023

BUY
$350.74 - $468.98 $415,276 - $555,272
1,184 Added 40.31%
4,121 $1.93 Million
Q1 2023

May 02, 2023

SELL
$310.63 - $364.82 $347,905 - $408,598
-1,120 Reduced 27.61%
2,937 $1.01 Million
Q4 2022

Feb 07, 2023

BUY
$321.55 - $374.67 $2,893 - $3,372
9 Added 0.22%
4,057 $1.48 Million
Q3 2022

Nov 03, 2022

BUY
$296.48 - $337.87 $63,150 - $71,966
213 Added 5.55%
4,048 $1.44 Million
Q2 2022

Aug 01, 2022

SELL
$278.73 - $327.27 $4,738 - $5,563
-17 Reduced 0.44%
3,835 $1.26 Million
Q1 2022

May 02, 2022

BUY
$234.69 - $291.66 $234 - $291
1 Added 0.03%
3,852 $1.1 Million
Q3 2021

Nov 01, 2021

BUY
$221.6 - $272.71 $3,988 - $4,908
18 Added 0.47%
3,851 $981,000
Q2 2021

Aug 02, 2021

SELL
$180.55 - $233.54 $9,930 - $12,844
-55 Reduced 1.41%
3,833 $933,000
Q1 2021

Apr 21, 2021

SELL
$164.32 - $212.72 $8,708 - $11,274
-53 Reduced 1.34%
3,888 $741,000
Q4 2020

Feb 16, 2021

BUY
$130.46 - $172.63 $514,142 - $680,334
3,941 New
3,941 $817,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $805B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Bcgm Wealth Management, LLC Portfolio

Follow Bcgm Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bcgm Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bcgm Wealth Management, LLC with notifications on news.